ChatGPT-Maker OpenAI's CEO Sam Altman Makes Shocking Admission Before US Lawmakers, Says 'If AI Goes Wrong, It Can Go Quite Wrong'
Sam Altman, CEO of Microsoft-backed OpenAI, has admitted that if generative artificial intelligence (AI) technology goes wrong, it can go quite wrong, as US senators expressed their fears about AI chatbots like ChatGPT.
San Francisco, May 17: Sam Altman, CEO of Microsoft-backed OpenAI, has admitted that if generative artificial intelligence (AI) technology goes wrong, it can go quite wrong, as US senators expressed their fears about AI chatbots like ChatGPT.
Sam Altman, who testified at a hearing in the US Senate in Washington, DC, late on Tuesday, said that the AI industry needs to be regulated by the government as AI becomes "increasingly powerful".
"If this technology goes wrong, it can go quite wrong," Altman told them. The US Senators grilled him about the potential threats AI poses and raised fears over the 2024 US election. Bard Feature Update: Google's AI Chatbot Will Now Offer Improved Summaries With Sources.
"If you were listening from home, you might have thought that voice was mine and the words from me, but in fact, that voice was not mine," said US Senator Richard Blumenthal. He added that AI is more than just research experiments and is real and present.
Altman said he doesn't make money from OpenAI. He told the committee that OpenAI is working on a copyright system to compensate artists whose art was used to create something new. "Creators deserve control," he said.
The losses of OpenAI reportedly swelled to nearly $540 million last year and are likely to only keep rising. According to The Information, OpenAI's losses doubled as it developed ChatGPT and hired key employees from Google.
OpenAI, in February this year, launched the new subscription plan, ChatGPT Plus, which is available for $20 a month. AI To Detect Diabetic Kidney Disease: US Researchers Develop Artificial Intelligence-Based Approach To Predict if Person With Type 2 Diabetes Will Develop Kidney Disease.
Meanwhile, Altman's comments came as the WHO said that carefully examining the risks involved is imperative while using artificial intelligence (AI) tools such as ChatGPT and Bard in healthcare.
"There is concern that caution that would normally be exercised for any new technology is not being exercised consistently with large language model tools (LLMs)", the global health agency said.
(The above story first appeared on LatestLY on May 17, 2023 09:53 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).